MOXAM Drug Patent Profile
✉ Email this page to a colleague
When do Moxam patents expire, and what generic alternatives are available?
Moxam is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in MOXAM is moxalactam disodium. There is one drug master file entry for this compound. Additional details are available on the moxalactam disodium profile page.
Summary for MOXAM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Patent Applications: | 4,614 |
DailyMed Link: | MOXAM at DailyMed |
US Patents and Regulatory Information for MOXAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | MOXAM | moxalactam disodium | INJECTABLE;INJECTION | 050550-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | MOXAM | moxalactam disodium | INJECTABLE;INJECTION | 050550-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | MOXAM | moxalactam disodium | INJECTABLE;INJECTION | 050550-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | MOXAM | moxalactam disodium | INJECTABLE;INJECTION | 050550-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | MOXAM | moxalactam disodium | INJECTABLE;INJECTION | 050550-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |